featured
SGLT2 Inhibition and Cardiovascular Events
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetologia
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
SGLT2 Inhibition and Cardiovascular Events: Why Did EMPA-REG Outcomes Surprise and What Were the Likely Mechanisms?
Diabetologia 2016 Apr 25;[EPub Ahead of Print], N Sattar, J McLaren, SL Kristensen, D Preiss, JJ McMurrayFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.